The global MRI safe implantable defibrillator devices market would reach US$ 890 Mn in 2022 with a CAGR of 6.7% from 2022 to 2032. By 2032, it is expected that the market for MRI-safe implantable defibrillator devices would develop at a CAGR of 6.7% and reach US$ 1.7 billion.
As the population ages, cardiac problems rise, and product technology advances, there is an increasing demand for MRI safe implantable defibrillator devices. The leads of cardiac pacemakers or defibrillators are projected to be affected by the various electromagnetic fields employed during MRI imaging operations.
Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=566?AS
Market Participants
- Medtronic plc
- Zimmer Holdings Inc.
- Abbott Laboratories
- Cochlear Ltd.
- Biotronik
- Boston Scientific Corporation
- St. Jude Medical Inc
- Smiths Medical
- AbbVie, Inc.
- TriVascular2, Inc.
- Stryker Corporation
- Smith & Nephew Plc
- Johnson & Johnson
Key Statistics Supporting the Surge
- In 2022, North America is expected to account for 24.1% of the global market share.
- North America dominates the market for MRI safe implantable defibrillator solutions because of the region’s sophisticated medical facilities, high rate of implants, and favourable reimbursement environment.
- Europe is predicted to hold 22.3% of the global market share, in 2022.
- Growing geriatric population is one of the factors driving the MRI Safe Implantable Defibrillator Devices Market.
- The global MRI safe defibrillator devices market has been divided into hospitals and ambulatory surgical centers, based on end user
“Rising incidences of Chronic Ailments to hold the hopes high for MRI Safe Implantable Defibrillator Market” says a Fact.MR analyst.
Market Developments
There are incredibly few businesses that are engaged in the production of MRI-compatible gadgets. These products were just recently introduced into the market.
- In April 2014, Medtronic announced that the first implantable defibrillator devices that were MRI-safe had received the CE Mark and were available in Europe.
- USFDA recently approved the first Medtronic ICD that is MRI-compatible. A majority of the population still uses implantable defibrillators that are not MRI-compatible despite the introduction of MRI-safe devices.
Market participants will put more effort into creating novel devices to attract attention across the world. Since 2021, the most frequently used strategies have continued to include technological improvements, new product launches, research and development, acquisitions, expansions, and collaborations.
- DirectSense Technology, a novel instrument for observing the impact of radiofrequency energy delivery during cardiac ablation procedures, was recently released by Boston Corporation.
Industry Research
- by Product :
- Single Chamber Defibrillators
- Dual Chamber Defibrillators
- Modality :
- MR Conditional Defibrillators
- MR Safe Defibrillators
- by End Use :
- Hospitals
- Ambulatory Surgical Centers
- by Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
The MRI-safe implantable defibrillator devices research clears away the following queries:
- What is the present and future outlook of the global MRI-safe implantable defibrillator devices based on region?
- What tactics are the MRI-safe implantable defibrillator devices vendors implementing to give tough competition to their business counterparts?
- What are the macro- and microeconomic factors affecting the global MRI-safe implantable defibrillator devices?
- Which end use segment is spectated to lead by the end of 2032?
- Why region has the highest consumption of MRI-safe implantable defibrillator devices?
Choosing Fact.MR – Reasons to Stay Ahead of the Curve
- Provides latest and comprehensive details of industry trends
- Provides round the clock support to clients for foolproof solutions
- Provides help with supply chain augmentation
- Provides optimal, innovative, and viable business solutions
- Provides custom or tailor made reports to fit the dynamic and specific needs of client
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=566?AS
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: [email protected]